NASDAQ:ICPT
Delisted
Intercept Pharmaceuticals Stock News
$19.00
+0 (+0%)
At Close: Feb 06, 2024
Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC
08:30am, Thursday, 29'th Feb 2024
MORRISTOWN, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commerci
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
09:13am, Wednesday, 08'th Nov 2023
BOLOGNA, Italy and MORRISTOWN, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. (“Intercept”) announced today the completion of the ac
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
09:12am, Wednesday, 08'th Nov 2023
BOLOGNA, Italy & MORRISTOWN, N.J.--(BUSINESS WIRE)--Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. ( “Intercept”) announced today the completion of the acquisition of Inter
Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.
02:08am, Wednesday, 08'th Nov 2023
BOLOGNA, Italy--(BUSINESS WIRE)--Alfasigma S.p.A. (“Alfasigma”) announced today that it has, through its wholly owned subsidiary Interstellar Acquisition Inc. (“Interstellar”), successfully co
Will Intercept Pharmaceuticals (ICPT) Report Negative Q3 Earnings? What You Should Know
11:17am, Tuesday, 31'st Oct 2023
Intercept (ICPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now
07:03am, Thursday, 19'th Oct 2023
In rough markets it's important to keep and eye out for overbought stocks. Finding the right timing to buy and sell stocks will always be a sought-after skill by any investor searching for that holy g
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intercept Ph
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intercept Ph
LOS ANGELES, CA / ACCESSWIRE / September 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Intercept Ph
Intercept Pharmaceuticals (ICPT) Surges on Acquisition Deal
11:17am, Wednesday, 27'th Sep 2023
Intercept Pharmaceuticals (ICPT) gains an acquisition deal from Alfasigma for $19.00 per share in cash.
Intercept (ICPT) Stock Jumps 79.2%: Will It Continue to Soar?
06:46am, Wednesday, 27'th Sep 2023
Intercept (ICPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Intercept Pharmaceuticals Stock Is Skyrocketing Today
02:17pm, Tuesday, 26'th Sep 2023
The stock is exploding following an announcement that it's on track to be acquired. Alfasigma is poised to buy Intercept at a price of $19 per share.
Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?
02:11pm, Tuesday, 26'th Sep 2023
Amid a rough day on Wall Street, Intercept Pharmaceuticals (NASDAQ: ICPT ) represented a bright spot, with shares swinging up 75% before slightly adding to those gains. Catapulting the biopharmaceutic
MILWAUKEE , Sept. 26, 2023 /PRNewswire/ -- Ademi LLP is investigating Intercept (Nasdaq: ICPT) for possible breaches of fiduciary duty and other violations of law in its transaction with Alfasigma.
Intercept Pharmaceuticals stock soars on Alfasigma acquisition deal
11:42am, Tuesday, 26'th Sep 2023
Intercept Pharmaceuticals (NASDAQ:ICPT) Inc shares surged 79% to $18.64 in late-morning trading on Tuesday after the biopharmaceutical company specializing in rare and serious liver diseases announce